Concepedia

Zoe Kelly

ZK

5

Publications

293

Citations

5

H-Index

2005

Active since

Affiliations

Agency for Science, Technology and Research(Current)

National University Health System

University of Surrey

Institute of Molecular and Cell Biology

National University Cancer Institute, Singapore

Zoe Kelly is an author at Agency for Science, Technology and Research specializing in tumor biology, medicine, and ovarian cancer.

ORCID

Top concepts

Publications per year

2005–2018

5

Publications

5

The GAS6-AXL signaling network is a mesenchymal (Mes) molecular subtype–specific therapeutic target for ovarian cancer

Jane Antony, Tuan Zea Tan, Zoe Kelly et al. · Science Signaling · 2016 · 116 citations

HOX genes in ovarian cancer

Zoe Kelly, Agnieszka Michael, Simon Butler‐Manuel et al. · Journal of Ovarian Research · 2011 · 70 citations · Full text

The prognostic significance of specific <i>HOX</i> gene expression patterns in ovarian cancer

Zoe Kelly, Carla S. Möller‐Levet, Sophie McGrath et al. · International Journal of Cancer · 2016 · 60 citations · Full text

, , +14

The tumour suppressor <scp>OPCML</scp> promotes <scp>AXL</scp> inactivation by the phosphatase <scp>PTPRG</scp> in ovarian cancer

Jane Antony, Elisa Zanini, Zoe Kelly et al. · EMBO Reports · 2018 · 32 citations · Full text

, , +8

DNA Microarray-Based Gene Expression Profiling in Cancer: Aiding Cancer Diagnosis, Assessing Prognosis and Predicting Response to Therapy

Michael J. Duffy, Zoe Kelly, Aedín C. Culhane et al. · Current Pharmacogenomics · 2005 · 15 citations

, , +22

Rows per page

1–5 of 5